Explantation of silicone breast implants

Area of Science:

• Plastic Surgery
• Biomaterials Science
• Rheumatology

Background:

• Silicone gel-filled breast implants are widely used for augmentation and reconstruction.
• Concerns exist regarding potential systemic health issues linked to these implants.
• Reported sequelae include autoimmune and inflammatory conditions.

Purpose of the Study:

• To evaluate patient-reported symptoms and outcomes following explantation of silicone gel breast implants.
• To assess the safety and efficacy of explantation and potential replacement with saline devices.
• To review the literature on silicone implant-associated complications.

Main Methods:

• Retrospective analysis of 25 patients undergoing explantation of silicone gel implants over 24 months.
• Documentation of patient-reported symptoms pre- and post-explantation.
• Clinical examination, mammography, and histopathologic analysis of explanted tissues.
• Review of existing medical literature on silicone implant complications.

Main Results:

• Patient symptoms included mastodynia, arthralgia, fibromyalgia, and visual disturbances.
• Implant rupture was detectable by imaging, but leakage required re-exploration.
• Histopathology showed chronic inflammation in all tissue samples.
• 20% morbidity was observed, with subjective symptom improvement post-explantation.

Conclusions:

• A subset of patients may experience chronic morbidity from silicone gel implants; identification is challenging.
• The link between silicone gel and systemic illness remains unproven but implicated.
• Symptomatic patients may benefit from explantation, understanding associated risks.
• Saline-filled devices may be preferable for new augmentations/reconstructions.
• Informed patient-physician dialogue on risks and benefits is crucial.